What are you looking for today?

Karkar, Yasir, Anis, Tanzeela, Elkordy, Amal Ali and Faheem, Ahmed M (2025) Flexipill: A novel 3D printed flexible dose combination with a floating element. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 212. p. 114736. ISSN 1873-3441

Full text not available from this repository. (Request a copy)

Abstract

Abstract

Hypertension is highly prevalent worldwide, affecting approximately one in three adults. The pathophysiology of hypertension is multifactorial, which led recent guidelines to recommend the initiation of treatment with more than one antihypertensive agent. This exacerbates the existing issue of polypharmacy, particularly among geriatric patients. Polypharmacy can lead to a reduction in patient adherence to the treatment. As a result, many clinical studies have investigated using fixed-dose combinations to address this issue. These studies have demonstrated the effectiveness of a polypill in improving patient adherence. However, a polypill limits the flexibility for dose titration and personalisation of treatment. Therefore, when 3D printing was first introduced to pharmaceutical formulation, researchers recognised the potential of this technology for drug personalisation and the creation of more flexible drug combinations. Nonetheless, regulatory concerns still limit the translation of these research efforts into clinical applications that can benefit the patient. Consequently, this study seeks to bridge the existing gap by identifying a balanced approach between regulatory requirements and the concept of personalised drug combinations. The Flexipill is a flexible dose combination that does not require printing at the pharmacy level. It can be printed at a quality-controlled facility and assembled according to patient needs at the point of care. In this work, an antihypertensive Flexipill was printed, with each unit having different drug release profiles and formulation requirements. The propranolol HCl unit was printed as a floating unit to improve its solubility and bioavailability. It floated for 9 h, releasing over 90 % of the drug content. The enalapril maleate unit was formulated to avoid thermal degradation by printing at 150 °C, which is lower than its degradation temperature. Moreover, hydrochlorothiazide was formulated to provide immediate release of over 90 % of the drug within the first hour. [Abstract copyright: Copyright © 2025. Published by Elsevier B.V.]

Item Type: Article
Uncontrolled Keywords: Floating tablet, Fused deposition modelling, Hypertension, 3D printing, Personalised medicine, Polypill
SWORD Depositor: Publication Router
Depositing User: Publication Router
URI: https://sure.sunderland.ac.uk/id/eprint/19088

Further Details

More Information

Uncontrolled Keywords
Floating tablet, Fused deposition modelling, Hypertension, 3D printing, Personalised medicine, Polypill
SWORD Depositor
Depositing User

Identifiers

Item ID
19088
Identification Number
ISSN
1873-3441

Users with ORCIDS

ORCID for Yasir Karkar

Catalogue record

Date Deposited
03 Jun 2025 09:00
Last Modified
03 Jun 2025 15:02

Contributors

Author
Tanzeela Anis
Author
Amal Ali Elkordy
Author
Ahmed M Faheem

University Divisions

Subjects

Actions (login required)

View Item (Repository Staff Only)